Loading, Please Wait...
NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky reminds investors that it has commenced an investigation of QIAGEN N.V. (“QIAGEN” or “the Company”) (NYSE: QGEN) concerning possible violations of federal securities laws.
On October 8, 2019, QIAGEN filed multiple press releases in its Form 6-K filed with the Securities and Exchange Commission. In these releases, the Company disclosed that its longtime Chairman and CEO Peer Schatz had retired abruptly. Further, the releases announced that QIAGEN would be shifting its global operations organization to a regional manufacturing structure in a move that would result in a restructuring charge of $260 - $265 million. Finally, the releases warned that Q3 2019 net sales growth would only be 3%, or 40% lower than its initial projections. To obtain additional information, go to:
or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171